General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

GPhC announcementOctober 13 2014

The pharmacy regulator has announced a review of its Conduct, Ethics and Performance Standards.

General Pharmaceutical Committee chairman Nigel Clarke has announced the review saying there needs to be a debate about professionalism at the heart of the review of core regulatory standards.

“The events at Mid-Staffordshire Foundation Trust in England, the Vale of Leven in Scotland and the hospitals in Port Talbot and Bridgend showed a failure in governance and regulation,” he said in a speech at the Pharmacy Show.

“But more starkly, they showed what happens when clinicians and those providing care forget what it means to be a professional; when they fail to show professionalism. It shows what happens when professionals, managers, and leaders are not putting patients first.

“We will shortly be starting a wide ranging programme of engagement with all our stakeholders to ask some fundamental questions of you, the pharmacy professions, about what you see as professionalism in action; and how you think our standards best reflect this.

“We want this to be an open discussion, covering not just the things we can all agree on, but also the difficult issues pharmacy professionals face on a day to day basis ... I want everyone in pharmacy to have an opportunity to contribute. So, we have set ourselves the task of engaging with the profession on an even larger scale than has gone before. I would encourage everyone to become involved.”

Links:

GPhC statement

GPhC chairman’s speech

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...